Table 1.

Patient characteristics.

Total participants (n)	205
Median age, (range), in years	70 (44–87)
Median clinical target volume, (range), [interquartile range], in cubic centimeters (cc)	58.7 cc (46.4–75.4 cc) [23.8–154.3 cc]
Median initial PSA, (range)	6.9 ng/mL (0.05–70 ng/mL)
Distribution of T stage (%)
cT1c	72.5%
cT2a	19.4%
cT2b	3.3%
cT2C	1.4%
cT3a	1.9%
cT3b	0.5%